Counterbalance of Foxp3 and IDO expression at different tumor stages in aggressive breast cancer subtypes
R. Canzoneri, E. Lacunza, M. E. Rabassa, F. A. Cavalli, V. A. Ferretti, L. A. Barbera, A. Creton, M. V. Croce, M. T. Isla Larrain
This study examines Foxp3 and IDO1 expression in breast cancer across tumor stages and subtypes, finding their differential association with immune markers and suggesting potential roles in immunotherapy targets.
bioRxiv · Aug 23, 2021 · PreprintCancer Biology